Mark A. Mintun,Albert Lo,Cynthia Evans,Alette M. Wessels,Paul Ardayfio,Scott W. Andersen,Sergey Shcherbinin,JonDavid Sparks,John R. Sims,Mirosław Bryś,Liana G. Apostolova,Stephen Salloway,Daniel Skovronsky
A hallmark of Alzheimer's disease is the accumulation of amyloid-β (Aβ) peptide. Donanemab, an antibody that targets a modified form of deposited Aβ, is being investigated for the treatment of early Alzheimer's disease.
cdercder
冰魂
不倦
eee
bc
pluto
SYLH
昏睡的蟠桃
剑指东方是为谁
科研助手6
遇上就这样吧
8R60d8
YifanWang
单纯的文龙
余味
HeWang
科研小民工
小墨
归尘
shanage
皖公网安备34019202002308
